LMR Partners’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

LMR Partners’s Portfolio GRNAW Stock Details GRNAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,939,527	Closed	-$39.1K	–	1113
2023 Q2	$39.1K	Hold	2,939,527	–	–	﹤0.01%	684
2023 Q1	$1.27M	Hold	2,939,527	–	–	0.02%	542
2022 Q4	$3.47M	Hold	2,939,527	–	–	0.06%	357
2022 Q3	$6.82M	Buy	2,939,527 +319,152	+12%	+$96.9K	0.13%	213
2022 Q2	$5.79M	Buy	2,620,375 +1,473,061	+128%	+$1.19M	0.1%	254
2022 Q1	$11M	Buy	1,147,314 +947,314	+474%	+$693K	0.13%	165
2021 Q4	$0	Hold	200,000	–	–	﹤0.01%	1333
2021 Q3	$1.98M	Buy	+200,000	New	+$210K	0.02%	453

LMR Partners's GRNAW Position: Q3 2023 in Review

LMR Partners sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q3 2023, closing a stake of 2,939,527 shares — an estimated $39.1K sold.

LMR Partners first reported a position in GRNAW in Q3 2021 and held it in 8 quarters. The position peaked at $11M in Q1 2022. 1 fund tracked by Wall St. Rank holds GRNAW as of Q3 2023.

LMR Partners reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q3 2023 after selling out during the quarter.
LMR Partners sold 2,939,527 GreenLight Biosciences Holdings, PBC Warrant shares in Q3 2023, an estimated $39.1K.
LMR Partners first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q3 2021 and held it in 8 quarters.
LMR Partners's GreenLight Biosciences Holdings, PBC Warrant position peaked at $11M in Q1 2022.
1 fund tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q3 2023.

Based on LMR Partners's 13F filing for Q3 2023, filed 14 Nov 2023.